Nurocor offers a cloud-based software platform designed to improve efficiency, reusability, governance, and automation for pharmaceutical companies during the clinical development phase. Its solution is intended to significantly accelerate the typical clinical trial lifecycle and reduce the overall cost of clinical development. Founded in 2017, Nurocor says it is entering its next stage of growth and expects to partner with strategic investors to expand its offerings. In 2024 Simulations Plus invested $1 million in Nurocor through its Corporate Development Initiative to support early-stage technology companies. Simulations Plus indicated the investment could enable clients to deploy complementary solutions in clinical trial design, protocol development, and site competency and compliance. The company’s CEO, Alex Lazar, described the investment as a vote of confidence and said Nurocor looks forward to partnering with Simulations Plus to realize efficiencies through optimization and automation of clinical trials.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2025